Obesity, metabolic syndrome, and cardiovascular disease.
about
Role of lipotoxicity in endothelial dysfunctionAttenuation of obesity by early-life food restriction in genetically hyperphagic male OLETF rats: peripheral mechanisms.A repeated measurement study investigating the impact of school outdoor environment upon physical activity across ages and seasons in Swedish second, fifth and eighth graders.Long-term obesity levels in female OLETF rats following time-specific post-weaning food restriction.Inflammatory cytokine profiles during exercise in obese, diabetic, and healthy children.Cognitive function and overweight in preschool children.Risk factors for subclinical atherosclerosis in diabetic and obese children.Metabolic syndrome risk factors in overweight, obese, and extremely obese Brazilian adolescents.Challenges and Opportunities in the Management of Cardiovascular Risk Factors in Youth With Type 1 Diabetes: Lifestyle and Beyond.The association between metabolic syndrome and vascular endothelial dysfunction in adolescents.Growth inhibition and compensation in response to neonatal hypoxia in rats.School-based screening of the dietary intakes of third graders in rural Appalachian OhioToward an animal model of childhood-onset obesity: follow-up of OLETF rats during pregnancy and lactation.Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders.Enzyme-treated Ecklonia cava extract inhibits adipogenesis through the downregulation of C/EBPα in 3T3-L1 adipocytes.Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome.Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels.Childhood obesity-related endothelial dysfunction: an update on pathophysiological mechanisms and diagnostic advancements.Early echocardiography abnormalities in obese children and adolescent and reversibility of these abnormalities after significant weight reduction.Metabolic syndrome in obese adolescents.Cardiopulmonary Exercise Testing in Children and Adolescents with High Body Mass Index.Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity.Effect of maternal protein restriction during pregnancy and postweaning high-fat feeding on diet-induced thermogenesis in adult mouse offspring.Abnormal vascular reactivity at rest and exercise in obese boys.Relationship between childhood obesity cut-offs and metabolic and vascular comorbidities: comparative analysis of three growth standards.Anti-obesity effects of pectinase and cellulase enzyme‑treated Ecklonia cava extract in high‑fat diet‑fed C57BL/6N mice.Role of apathy in the effectiveness of weight management programmes.Expression of NO synthases and redox enzymes in umbilical arteries from newborns born small, appropriate, and large for gestational age.Early-onset metabolic syndrome in prepubertal obese children and the possible role of alanine aminotransferase as marker of metabolic syndrome.Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome.Adipokine update – neue Moleküle, neue FunktionenEarly Cardiac Abnormalities in Obese Children: Importance of Obesity Per Se Versus Associated Cardiovascular Risk Factors
P2860
Q27000731-D867F532-067F-4C40-995E-DDA5A12B6913Q33781165-36562BBC-5127-4BC4-9855-2DA55B4A6AEAQ34048380-5BDA522D-74A0-4393-9287-0FBA8D9850C6Q34316560-66FDECFB-95E7-4B35-952A-D0793451C55CQ35251581-E1EE74DC-2718-4D43-A59C-D93052E168C8Q36380059-7368D878-4756-44D3-9BB1-458DB23C4816Q36619217-D592CB39-9F94-4F9E-8E50-1767EC2A68E8Q36697888-84D231AE-5F66-434F-BD61-BD5EFA53277AQ36969372-25AFE54A-7B91-4D95-AE54-98BFC9FA0AC7Q36986439-6DD84FEB-3722-4CCF-866F-5E760FA2F84EQ37079987-0EFE72F5-A12E-458A-BFC5-BCAE0D638745Q37284358-8BECF48C-8883-49F0-930E-A7C6CBB5D491Q37325213-E3095A21-BF40-4EEC-83F6-E917EE6C28D3Q37366549-DD8FC9E2-DD88-4E3E-A83F-A16A94D9814BQ37714053-C96C21FF-EC34-4D06-86DD-20DBA04C0187Q38328903-D5A4F3D8-C1EB-408C-B2DE-B555D51AE9B5Q38348866-A8D6C044-E4B5-4AE7-86B2-941AFC2CD78BQ38729517-F25B4D59-58A6-48F5-9905-46AB02EC54E5Q39913889-AA5021A0-7F6C-4FAC-B2A9-0731D2DB9778Q39976188-6BD16C98-F8BD-4099-9C5C-37DEE6ED8207Q42125838-83D29BE2-F66C-4912-8A89-A53FBC2B276FQ43645634-A10C16F9-D4E0-40B6-88B2-D0F84042BCB5Q44485379-6500E891-FF78-4004-9D2A-89812033CC62Q46129998-E07F6D81-5464-488A-A8DF-808A02D86426Q46635641-9700B1B3-B32C-4984-956F-EB9C0D0D0A93Q47329207-4C03E9C9-0BAE-43E3-B92B-81F54438C6BFQ47339867-101C6BF9-A4F6-4B79-9079-85DC874F87CEQ50774879-60103870-0E24-4308-8546-406151411ABAQ51368407-EDB364A7-EB9E-4286-B1F5-9C32C0145602Q53031023-B184400E-8CEB-4160-BF96-1AB27DE173FDQ56656927-664318A2-9A0E-48D3-ADF8-35EF6B848081Q59180802-93DC3535-1F80-4CC3-B7F4-F0C0759FCDEC
P2860
Obesity, metabolic syndrome, and cardiovascular disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Obesity, metabolic syndrome, and cardiovascular disease.
@en
type
label
Obesity, metabolic syndrome, and cardiovascular disease.
@en
prefLabel
Obesity, metabolic syndrome, and cardiovascular disease.
@en
P2860
P921
P1433
P1476
Obesity, metabolic syndrome, and cardiovascular disease.
@en
P2093
Yacine Aggoun
P2860
P2888
P304
P356
10.1203/PDR.0B013E31805D8A8C
P407
P577
2007-06-01T00:00:00Z
P5875
P6179
1030679561